Stay updated on BMS-986288 Immunotherapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986288 Immunotherapy Combo Clinical Trial page.

Latest updates to the BMS-986288 Immunotherapy Combo Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the v3.3.3 entry was removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page history shows a new Revision: v3.3.3 entry added; the HHS Vulnerability Disclosure and Revision: v3.3.2 footer entries were removed.SummaryDifference0.1%

- Check40 days agoChange DetectedVersion 43 (Revision: v3.3.2) adds multiple study-content sections (Outcome Measures, Baseline Characteristics, Participant Flow, Study Status) and a QC status. It also includes dated entries (2025-11-20, 2025-12-04) and replaces Revision: v3.3.1.SummaryDifference0.6%

- Check55 days agoChange DetectedThe changes involve a site UI revision from version v3.2.0 to v3.3.1 on the page, with no changes to study data, records, or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe funding/operating status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedAdverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and References were added to the study record. The page now shows an updated Study Status with a Quality Control Review indicated as Has Not Concluded.SummaryDifference0.7%

Stay in the know with updates to BMS-986288 Immunotherapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986288 Immunotherapy Combo Clinical Trial page.